Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight BARDA - ASPR / DAAPPO / BARDA DCMADCMA: the Defense agency that manages contracts after award: payments, quality checks, property and contractor business systems. Glossary (75A501) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $117K in FY2020; since FY2021, $83.2K in FY2024. See more on the Contracts tab
$14.9M since award = $457K in FY2021–FY2026 + $14.4M before FY2021
Click a state to open its page.
- New Jersey$14.4M · 97%
- Massachusetts$239K · 1.6%
- Iowa$169K · 1.1%
- Maryland$91.3K · 0.6%
Insight 97% was performed in New Jersey. See more on the Contracts tab
Contracts
7 contracts with an action since FY2021
Click a bar to open its contract.
Insight Stand-alone contracts hold 100% of these contracts' obligations.
Click a bar to open its industry page.
Insight 51% under NAICS 334516.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
Repligen Corporation prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–7 of 7 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 75A50121P00074 | Stand-alone | BARDA - ASPR / DAAPPO / BARDA DCMA (75A501) | $14,372,753 | Aug 31, 2035 | Running |
| 75F40126P00067 | Stand-alone | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $174,560 | Sep 30, 2026 | Ended |
| 12639526P0246 | Stand-alone | MRPBS MINNEAPOLIS MN (126395) | $169,186 | Sep 28, 2026 | Ended |
| HT942524P0046 | Stand-alone | ARMY MED RES ACQ ACTIVITY (HT9425) | $48,742 | May 29, 2026 | Ended |
| W81XWH20P0093 | Stand-alone | W4PZ USA MED RSCH ACQUIS ACT (W81XWH) | $42,538 | May 28, 2020 | Ended |
| 75F40124P00470 | Stand-alone | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $34,420 | Nov 15, 2024 | Ended |
| 75N93022P00466 | Stand-alone | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $30,465 | Mar 14, 2023 | Ended |
Buyers
Click a bar to open its office page.
Insight Office of Assistant Secretary for Preparedness and Response placed 97%.
Contracting offices that awarded Repligen Corporation prime contracts, FY2021–FY2026
See which offices award its contracts.
5 offices awarded only one contract.
Showing 1–6 of 6 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| BARDA - ASPR / DAAPPO / BARDA DCMA (75A501) | Office of Assistant Secretary for Preparedness and Response | 1 | $14,372,753 | Sep 30, 2021 | Apr 21, 2026 |
| FDA OFFICE OF ACQ GRANT SVCS (75F401) | Food and Drug Administration | 2 | $208,980 | Sep 16, 2024 | May 28, 2026 |
| MRPBS MINNEAPOLIS MN (126395) | Animal and Plant Health Inspection Service | 1 | $169,186 | Sep 1, 2026 | Sep 1, 2026 |
| ARMY MED RES ACQ ACTIVITY (HT9425) | Defense Health Agency | 1 | $48,742 | Jan 31, 2024 | Nov 14, 2024 |
| W4PZ USA MED RSCH ACQUIS ACT (W81XWH) | Department of the Army | 1 | $42,538 | May 20, 2020 | Jan 12, 2021 |
| NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | National Institutes of Health | 1 | $30,465 | Mar 14, 2022 | Apr 25, 2022 |
Teaming
Subcontracts Repligen Corporation received, by prime order
Whom it works under and on what.
6 subcontracts from 3 primes.
Showing 1–6 of 6 subcontracts
| Leidos Biomedical Research Inc. | 75N91020F00006under 75N91019D00024 | NIH NCI (75N910) | $333,000 | Jan 29, 2024 |
| Leidos Biomedical Research Inc. | HHSN26100050under HHSN261201500003I | NIH NCI (75N910) | $117,108 | May 2, 2023 |
| Leidos, Inc. | 89243318CFE000003 | NATIONAL ENERGY TECHNOLOGY LABORATORY (892433) | $79,853 | Dec 21, 2023 |
| Leidos Biomedical Research Inc. | 75N91020F00003under 75N91019D00024 | NIH NCI (75N910) | $37,415 | May 2, 2023 |
| Colorado State University | 75N93020C00053 | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $31,645 | Jun 22, 2022 |
| Colorado State University | 75N93020C00051 | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $17,488 | Mar 2, 2021 |
Opportunities
Open opportunities matching Repligen Corporation's registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325414
3 of the next 3 are due within 30 days.
Showing 1–3 of 3 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| PANDHA-26-P-0000 046638 Defibrinated Rabbit Blood (opens in Procura)Special Notice · NAICS 325414Free account: full notice, dates, attachments | Defense Health Agency (DOD) | Oct 23, 2026 |
| Brand Name - Dectomax (Doramectin) 500mL Injectable Solution (opens in Procura)Combined Synopsis/Solicitation · Set aside: Small business · NAICS 325414Free account: full notice, dates, attachments | Animal and Plant Health Inspection Service (USDA)MRPBS MINNEAPOLIS MN (126395) | Oct 30, 2026 |
| Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC) (opens in Procura)Combined Synopsis/Solicitation · NAICS 325414Free account: full notice, dates, attachments | Animal and Plant Health Inspection Service (USDA)MRPBS MINNEAPOLIS MN (126395) | Nov 10, 2026 |
Registration and contacts
Registration
- UEI
- H9J9D228RFQ9
- CAGE code
- 1FHH9
- Registration
- Active, expires Aug 4, 2027
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- WALTHAM, MA, 02453
- Congressional district
- MA-05
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 325414
- 325414 Biological Product (except Diagnostic) ManufacturingPrimary
Contacts at Repligen Corporation
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Company contactSBA profileAs of Oct 4, 2026 | Oct 4, 2026 |
Correct this listing
Tell us what to correct or add on the Repligen Corporation page. We check every request before we change a profile.